Team:Groningen:Project:Detection/Infectedwounds

Resistance of anti-microbials, especially antibiotics, cause a major problem in modern medicine world. The World Health Organization state’s “A post-antibiotic era—in which common infections and minor injuries can kill—far from being an apocalyptic fantasy, is instead a very real possibility for the 21st century” (April, 2014)¹. Therefore we will not use antibiotics against the infections but rather use a set of Infection Preventing Molecules (IPMs). Little resistance has been shown for these molecules (Source, resistantie against Nsin) and are therefore excellent targets for our fight against infections. More about these IPMs can be read in our secretion page. To further lower the chance of resistance we integrate a detection system in our LactoAid. This detection system prevents unnecessary production of the IPMs and thus lowering the chance of resistance development in bacteria.

Our lactoAid focusses primarily on the treatment of burn wounds. The most occurring infections with burn wounds are caused by Staphylococcus aureus and Pseudonomas aeruginosa. Both these pathogenic (i.e. capable of causing disease) bacteria are opportunistic organisms. Meaning that they hardly infect healthy people, but when immunity is lowered or the skin is damaged they can cause infection. Only when the density of the pathogen is above a certain threshold it starts to transcribe pathogenic genes and produces toxins (García-Contreras, Maeda, & Wood, 2013).

The reason a single cell or low density population will not start to produce these toxins is because they cannot produce enough toxins to kill surrounding cells to start an infection. If a pathogen should do it, it would waste energy. Therefore the pathogens wait until the density is big enough to inflict damage by simultaneously producing the toxins. So how do the bacteria know when the optimal density is obtained? They secrete signal molecules The pathogens know how big their population is by secreting signaling molecules. This signaling is called quorum sensing (QS)(García-Contreras et al., 2013). We designed our LactoAid in such a way that it is able to detect the QS of both staphylococcus aureus and Pseudonomas aeruginosa.